PTGS2 and atopic eczema: It was found that lower levels of miRNA-26b contribute to enhancing inflammation via cyclooxygenase-2, but miRNA-26a/b also exhibited tumor-suppressive features and had an anti-inflammatory function in type-2 diseases such as atopic dermatitis and asthma [53,96].